Abivax SA Sponsored ADR ABVX
91.06
(3.81)
(4.02%)
as of 25 Sep
- Market cap
- $8.2B
- P/E
- 0.0×
Follow ABVX
| Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
Current Ratio |
2.20 | 1.09 | 1.47 | 2.37 | 1.13 | 4.08 | 1.82 | 8.75 |
Net Debt/EBITDA |
0.10 | (0.33) | (0.13) | 0.13 | (0.19) | 1.62 | 0.32 | 2.19 |
Debt/Assets |
20.17% | 40.10% | 47.66% | 48.43% | 51.84% | 16.96% | 46.87% | 0.32% |
Debt/Equity |
0.38 | 1.76 | 7.27 | 1.86 | 5.45 | 0.28 | 2.37 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.92 | 0.90 | 0.79 | 1.10 | 0.89 | 0.66 | 0.87 | 0.48 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | (0.67) | (0.37) | (0.58) | (0.13) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | (148.81%) | (451.99%) | (254.34%) | (317.63%) | (145.55%) | (148.96%) | (136.07%) | |
| 0.00% | (57.22%) | (58.92%) | (45.95%) | (62.40%) | (73.76%) | (66.21%) | (86.11%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (208.88%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(141.03%) | (2,068.10%) | (299.02%) | (99.31%) | (1,076.77%) | (68.14%) | (222.14%) | (68.55%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.59 | 0.62 | 0.45 | 0.29 | 0.33 | 0.08 | 0.12 | 0.04 |
Share Based Compensation of Revenue |
— | — | — | — | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(1.69) | (2.52) | (2.38) | (3.22) | (2.99) | (2.45) | (2.66) | (2.62) |
Cash per Share |
1.46 | 0.90 | 2.51 | 4.12 | 1.49 | 6.56 | 2.61 | 8.76 |
Shareholders Equity per Share |
3.23 | 1.09 | 0.40 | 1.95 | 0.40 | 4.93 | 0.70 | 7.41 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.23 | 1.09 | 0.40 | 1.95 | 0.40 | 4.93 | 0.70 | 7.41 |
Free Cash Flow |
(17.23) | (30.75) | (34.00) | (53.97) | (57.17) | (105.41) | (167.42) | (182.46) |
Working Capital |
13.06 | 1.51 | 14.19 | 49.12 | 4.27 | 233.70 | 82.97 | 552.38 |
Capital Expenditures |
(0.90) | (1.05) | (1.02) | (1.94) | (0.34) | (0.29) | (0.70) | (0.16) |
Net Current Asset Value |
(4.95) | (25.65) | (36.81) | (7.82) | (33.90) | 167.67 | 6.52 | 477.57 |
| Other line items | ||||||||
Quick Ratio |
2.18 | 1.06 | 1.45 | 2.22 | 1.13 | 4.08 | 1.82 | 8.75 |
Depreciation/Fixed assets |
0.49 | 0.60 | 0.61 | 1.74 | 0.30 | 0.81 | 0.41 | 0.51 |
Cash ROIC |
(28.91%) | (65.08%) | (41.03%) | (33.27%) | (75.75%) | (19.12%) | (54.32%) | (16.40%) |
Accounts Receivable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 9,003.86 | 63,638.19 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(1.69) | (2.52) | (2.38) | (3.22) | (2.98) | (2.44) | (2.64) | (2.62) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (0.02) | (0.01) | (0.01) | 0.00 |
Average Receivables |
— | 8.36 | 8.15 | 9.53 | 10.16 | 18.31 | 23.67 | 17.66 |
Average Payables |
— | — | — | — | — | 33.71 | 49.26 | 44.95 |
Average Inventory |
— | — | — | — | 8.78 | — | — | — |
Average Assets |
— | 59.92 | 72.65 | 106.37 | 102.55 | 216.79 | 288.03 | 441.60 |
Average Common Equity |
— | 23.04 | 9.47 | 19.22 | 20.15 | 109.86 | 128.03 | 279.47 |
Capex to Sales |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates · fundamentals updated 23 Sep 2026